ISRG
NASDAQHealthcareLoading…
Intuitive Surgical, Inc. - Common Stock
Sector: Healthcare•United States•Market Cap: $166.9B
Related News
Latest stories connected to ISRG
10/20More news →
- RS 65Down 10.1% in 4 Weeks, Here's Why Intuitive Surgical (ISRG) Looks Ripe for a TurnaroundZacks Investment Research•1d ago•Original source
- RS 65Intuitive Surgical, Inc. (NASDAQ:ISRG) Receives Average Recommendation of “Moderate Buy” from BrokeragesDefense World•3d ago•Original source
- RS 65Is Intuitive Surgical a Buy Right Now?The Motley Fool•4d ago•Original source
- RS 65ISRG's Margins Contract in Q4: Will Tariffs Continue to Hurt in 2026?Zacks Investment Research•Mar 24, 2026•Original source
- RS 65Intuitive Surgical, Inc. (ISRG) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research•Mar 24, 2026•Original source
- RS 65Robotics Is Booming — But Intuitive Surgical Stock Just Flashed A Death CrossBenzinga•Mar 20, 2026•Original source
- RS 65Bull of the Day: Intuitive Surgical (ISRG)Zacks Investment Research•Mar 19, 2026•Original source
- RS 65Ambulatory Surgery Centers: A Long-Term Growth Opportunity for ISRG?Zacks Investment Research•Mar 18, 2026•Original source
- RS 65Why Intuitive Surgical, Inc. (ISRG) Dipped More Than Broader Market TodayZacks Investment Research•Mar 13, 2026•Original source
Financials
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Revenue | 10.06B | 8.35B | 7.12B | 6.22B | 5.71B | 4.36B | 4.48B | 3.72B | 3.13B | 2.70B |
| Cost of Revenue | 3.42B | 2.72B | 2.39B | 2.03B | 1.75B | 1.50B | 1.37B | 1.12B | 934.80M | 814.30M |
| Gross Profit | 6.64B | 5.63B | 4.73B | 4.20B | 3.96B | 2.86B | 3.11B | 2.60B | 2.19B | 1.89B |
| Research and Development Expenses | 1.31B | 1.15B | 998.80M | 879.00M | 671.00M | 595.10M | 557.30M | 418.10M | 328.60M | 239.60M |
| General and Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 986.60M | 810.90M | 705.30M |
| Selling and Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General and Administrative Expenses | 2.38B | 2.14B | 1.96B | 1.74B | 1.47B | 1.22B | 1.18B | 986.60M | 810.90M | 705.30M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 3.70B | 3.29B | 2.96B | 2.62B | 2.14B | 1.81B | 1.74B | 1.40B | 1.14B | 944.90M |
| Cost and Expenses | 7.12B | 6.00B | 5.36B | 4.65B | 3.89B | 3.31B | 3.10B | 2.52B | 2.07B | 1.76B |
| Net Interest Income | 365.90M | 324.90M | 192.10M | 29.70M | 69.30M | 157.20M | 127.70M | 80.10M | 41.90M | 35.60M |
| Interest Income | 365.90M | 324.90M | 192.10M | 29.70M | 69.30M | 157.20M | 127.70M | 80.10M | 41.90M | 35.60M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation and Amortization | 677.10M | 462.00M | 435.20M | 365.80M | 310.20M | 276.20M | 203.00M | 122.80M | 99.10M | 92.10M |
| EBITDA | 3.62B | 2.81B | 2.17B | 1.94B | 2.13B | 1.33B | 1.58B | 1.32B | 1.16B | 1.05B |
| EBIT | 2.95B | 2.35B | 1.77B | 1.58B | 1.82B | 1.05B | 1.37B | 1.20B | 1.06B | 949.70M |
| Non Operating Income Excluding Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.50M |
| Operating Income | 2.95B | 2.35B | 1.77B | 1.58B | 1.82B | 1.05B | 1.37B | 1.20B | 1.05B | 945.20M |
| Total Other Income Expenses Net | 365.90M | 324.90M | 192.10M | 29.70M | 69.30M | 157.20M | 127.70M | 80.10M | 41.90M | 35.60M |
| Income Before Tax | 3.31B | 2.67B | 1.96B | 1.61B | 1.89B | 1.21B | 1.50B | 1.28B | 1.10B | 980.80M |
| Income Tax Expense | 434.80M | 336.30M | 141.60M | 262.40M | 162.20M | 140.20M | 120.40M | 154.50M | 436.50M | 244.90M |
| Net Income From Continuing Operations | 2.88B | 2.34B | 1.82B | 1.34B | 1.73B | 1.07B | 1.38B | 1.13B | 670.90M | 735.90M |
| Net Income From Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Adjustments To Net Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 2.88B | 2.34B | 1.82B | 1.34B | 1.73B | 1.07B | 1.38B | 1.13B | 660.00M | 735.90M |
| Net Income Deductions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrom Line Net Income | — | — | — | — | — | — | — | — | — | — |
| EPS | 8 | 6.54 | 5.12 | 3.72 | 4.79 | 3.02 | 3.98 | 3.31 | 1.97 | 2.13 |
| EPS Diluted | 7.87 | 6.42 | 5.03 | 3.65 | 4.66 | 2.94 | 3.85 | 3.16 | 1.89 | 2.08 |
| Weighted Average SHS Out | 356.90M | 355.20M | 351.20M | 355.70M | 356.10M | 351.00M | 346.20M | 341.10M | 335.10M | 344.70M |
| Weighted Average SHS Out Dil | 362.70M | 362.00M | 357.40M | 362.00M | 365.80M | 360.90M | 358.50M | 356.40M | 348.90M | 353.70M |
| Fiscal Year (FMP) | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K |
| Gross Profit Margin | 0.66 | 0.67 | 0.66 | 0.67 | 0.69 | 0.66 | 0.69 | 0.7 | 0.7 | 0.7 |
| R&D to Revenue | 0.13 | 0.14 | 0.14 | 0.14 | 0.12 | 0.14 | 0.12 | 0.11 | 0.11 | 0.09 |
| SG&A to Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.26 | 0.26 | 0.26 |
| Interest Burden | 1.12 | 1.14 | 1.11 | 1.02 | 1.04 | 1.15 | 1.09 | 1.07 | 1.03 | 1.03 |
| EBIT Margin | 0.29 | 0.28 | 0.25 | 0.25 | 0.32 | 0.24 | 0.31 | 0.32 | 0.34 | 0.35 |
| EBITDA Margin | 0.36 | 0.34 | 0.3 | 0.31 | 0.37 | 0.3 | 0.35 | 0.36 | 0.37 | 0.39 |
| EBT per EBIT | 1.12 | 1.14 | 1.11 | 1.02 | 1.04 | 1.15 | 1.09 | 1.07 | 1.04 | 1.04 |
| Effective Tax Rate | 0.13 | 0.13 | 0.07 | 0.16 | 0.09 | 0.12 | 0.08 | 0.12 | 0.4 | 0.25 |
| Tax Burden | 0.86 | 0.87 | 0.92 | 0.82 | 0.9 | 0.88 | 0.92 | 0.88 | 0.6 | 0.75 |
| Cont. Operations Profit Margin | 0.29 | 0.28 | 0.26 | 0.22 | 0.3 | 0.24 | 0.31 | 0.3 | 0.21 | 0.27 |
| Bottom Line Profit Margin | 0.28 | 0.28 | 0.25 | 0.21 | 0.3 | 0.24 | 0.31 | 0.3 | 0.21 | 0.27 |
| Operating Cycle | 255.28 | 259.02 | 250.99 | 223.86 | 179.42 | 207.49 | 216.58 | 200.15 | 153.43 | 139.78 |
| Fwd PEG Ratio | 3.17 | 2.88 | 1.75 | -3.2 | 1.28 | -3.74 | 2.44 | 0.71 | -8.22 | 1.57 |
| Earnings Yield | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 |
| Income Quality | 1.05 | 1.03 | 1 | 1.11 | 1.21 | 1.39 | 1.16 | 1.04 | 1.73 | 1.42 |